Regenerative Medical Technology (RMTG) EPS (Basic) (QoQ) (2018 - 2026)
Regenerative Medical Technology (RMTG) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.52% |
| Dec 31, 2025 | 41.67% |
| Sep 30, 2025 | -201.56% |
| Jun 30, 2025 | -71.57% |
| Mar 31, 2025 | -18.99% |
| Dec 31, 2024 | 27.82% |
| Sep 30, 2024 | 57.48% |
| Jun 30, 2024 | -5.94% |
| Mar 31, 2024 | -141.33% |
| Dec 31, 2023 | 372.51% |
| Sep 30, 2023 | -299.64% |
| Jun 30, 2023 | 24.96% |
| Mar 31, 2023 | -926.27% |
| Dec 31, 2022 | 15,961.60% |
| Sep 30, 2022 | -308.07% |
| Jun 30, 2022 | 266.03% |
| Mar 31, 2022 | -100.01% |
| Dec 31, 2021 | 112.29% |
| Sep 30, 2021 | -1,196.25% |
| Jun 30, 2021 | -46.49% |